Excellos

Excellos accelerates gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services: from customized collection to engineered working cell banks. Our proprietary Excellos 360 technology provides deep characterization of cells to better match patient and therapeutic development needs. Prior to Excellos, Heather held roles at CDMOs as Head of Manufacturing and MSAT for Abzena, and Head of Quality at SAFC (now Millipore Sigma). Trust Excellos as your cell therapy CDMO to support your programs in adoptive cell therapies including: TIL Therapy, Autologous and Allogeneic CAR-T/NK Therapies, and TCR Therapy. Excellos is backed by the San Diego Blood Bank (established in 1950). Excellos works under a comprehensive quality assurance umbrella including Quality by Design (QBD) and Manufacturing by Design (MBD). With Excellos products you get excellent characterization information that can include: BMI, age, longitudinal data, HLA type, and telomere scores. We provide a continuum of services from donor recruitment to establishment of genetically modified working cell banks.